Tumor antigen based on products of the tumor suppressor gene WT1
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 14, 2009
Grant Date -
May 4, 2006
app pub date -
Jan 3, 2006
filing date -
Jul 31, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A tumor antigen that comprises, as an active ingredient, a product of the Wilms' tumor suppressor gene WT1 or a peptide composed of 7-30 contiguous amino acids containing an anchor amino acid for binding to major histocompatibility complex (MHC) class I in said amino acid sequence, and a vaccine comprising said antigen.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully